Kestra Medical Technologies
- Market cap
- 1.58B
- P/E (TTM)i
- -10.47
- P/Bi
- 7.10
- EPSi
- -2.43
- Div yieldi
- 0.00%
- 52W posi
- 72%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.8 percentage points.
Institutional ownership
- Held by institutions
- 104.53% -1.85pp
- Institutions
- 141 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-09-09
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 15 buys · 35 sells
| Name | Role | Stake |
|---|---|---|
| Bain Capital, LP | -- | 42.26% |
| Brian Webster | Chief Executive Officer | 0.55% |
| Traci Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director | 0.25% |
| Alfred Ford | Chief Commercial Officer | 0.09% |
| Raymond Cohen | Independent Director | 0.08% |
| Mary Ladone | Independent Director | 0.06% |
| Timothy Moran | Chief Business Officer | 0.04% |
| Vaseem Mahboob | Chief Financial Officer | 0.03% |
| Jeffrey Schwartz | Independent Chairperson | 0.01% |
| Elizabeth Kwo | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Raymond Cohen | Independent Director | Open Market Disposition | -3,330 | $29.28 |
| 2026-09-20 | Elizabeth Kwo | Independent Director | Open Market Disposition | -4,010 | $24.26 |
| 2026-09-08 | Raymond Cohen | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Mary Ladone | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Conor Hanley | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Jeffrey Schwartz | Independent Chairperson | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Elizabeth Kwo | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Kevin Reilly | Former Director | Other Acquisition | +7,217 | -- |
| 2026-09-07 | Mary Ladone | Independent Director | Open Market Disposition | -3,908 | $25.20 |
| 2026-09-07 | Conor Hanley | Independent Director | Open Market Disposition | -5,694 | $25.25 |
| 2026-09-07 | Jeffrey Schwartz | Independent Chairperson | Open Market Disposition | -3,890 | $25.18 |
| 2026-09-07 | Kevin Reilly | Former Director | Open Market Disposition | -2,932 | $25.13 |
| 2026-08-16 | Brian Webster | Chief Executive Officer | Automatic Disposition | -15,000 | $27.48 |
| 2026-08-06 | Vaseem Mahboob | Chief Financial Officer | Automatic Disposition | -26,287 | $25.87–26.33 |
| 2026-08-03 | Brian Webster | Chief Executive Officer | Open Market Disposition | -51,900 | $24.47–25.98 |
| 2026-08-03 | Alfred Ford | Chief Commercial Officer | Open Market Disposition | -6,275 | $24.09 |
| 2026-08-03 | Traci Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director | Open Market Disposition | -3,580 | $24.04 |
| 2026-08-03 | Vaseem Mahboob | Chief Financial Officer | Automatic Disposition | -3,915 | $25.17 |
| 2026-08-03 | Vaseem Mahboob | Chief Financial Officer | Open Market Disposition | -3,080 | $24.06 |
| 2026-08-02 | Brian Webster | Chief Executive Officer | Open Market Disposition | -29,822 | $22.60–23.92 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.